Product Information

CLOBETASOL 0.05% GEL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.0801 per GM under NDC 45802092514. Its NADAC has been published 669 times since Nov 28, 2013.

FDA first approved this application on Oct 31, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Clobetasol propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CLOBETASOL 0.05% GEL

Clobetasol propionate
$1.0801per GM
High Outlier

Strength

.5 mg/g

NDC

45802092514

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

CLOBETASOL PROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA075027

FDA Approved

10/31/1997

TE Code

AB

On Market Since

7/30/2008

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for CLOBETASOL 0.05% GEL has been published 669 times since Nov 28, 2013, and over the history we have for it it has risen 129.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0801 per GM
All-time high$5.5771 (Jan 14, 2015)
All-time low$0.4386 (Oct 20, 2021)
52-week high$1.0801
52-week low$0.5915
Median price$1.1025
Average price$1.7783
Largest weekly change+979.2% (Sep 10, 2014)
Weeks tracked669
Tracking sinceNov 28, 2013

Price History

1W

+2.1%

1M

+25.2%

3M

+52.1%

6M

+58.2%

1Y

+54.9%

3Y

+2.1%

5Y

+146.3%

All

+129.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clobetasol propionate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLOBETASOL 0.05% GEL?

The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% GEL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.0801 per GM (NDC 45802092514), effective Nov 18, 2026.

How has the price of CLOBETASOL 0.05% GEL changed over time?

Over the history we have for it, the NADAC for CLOBETASOL 0.05% GEL has risen 129.2%. It has been tracked across 669 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% GEL?

Since Nov 28, 2013, the NADAC for CLOBETASOL 0.05% GEL has ranged from a low of $0.4386 (Oct 20, 2021) to a high of $5.5771 (Jan 14, 2015), with a median of $1.1025 per GM.

Are there cheaper alternatives to CLOBETASOL 0.05% GEL?

No other NADAC-published product currently shares the active ingredient and strength of CLOBETASOL 0.05% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLOBETASOL 0.05% GEL?

CLOBETASOL 0.05% GEL (NDC 45802092514) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.